RecruitingNCT00005095

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Northwestern Ovarian Cancer Early Detection & Prevention Program: A Specimen and Data Study


Sponsor

Northwestern University

Enrollment

6,000 participants

Start Date

Mar 1, 2000

Study Type

OBSERVATIONAL

Conditions

Summary

RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study collects blood and tissue samples from women at increased risk of ovarian cancer, or those undergoing gynecologic surgery, to help develop better tools for early detection and prevention. **You may be eligible if...** - You are between 18 and 80 years of age - You have at least one first-degree relative (mother, sister, daughter) with ovarian cancer - You or your family have a hereditary cancer syndrome such as BRCA1/2 or Lynch Syndrome - A certified genetic counselor has determined you are at increased risk - You are having gynecologic surgery for any reason, including cancer, a benign condition, or preventive removal of ovaries **You may NOT be eligible if...** - You fall outside the age range of 18–80 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCa-125

Subject's blood collected at their follow-up blood draw will be assessed for biomarkers that could lead to a panel for detecting early stage ovarian cancer.

OTHERscreening questionnaire administration

Questionnaires designed to assess quality of life for women at increased risk of ovarian cancer will be administered to the subjects. Clinical data will also be collected.

PROCEDURESurgery

Subjects will be assessed for high risk factors.


Locations(1)

Robert H. Lurie Comprehensive Cancer Center at Northwestern University

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00005095


Related Trials